title: New evidence on old drugs; warfarin versus aspirin after bioprosthetic aortic valve placement.
authors.affiliation: Department of Medicine, Intermountain Medical Center, Murray, UT, United States; Department of Internal Medicine, University of Utah, Salt Lake City, UT, United States. Electronic address: scott.stevensmd@imail.org.
authors.forename: Scott M
authors.initials: SM
authors.lastname: Stevens
authors.affiliation: Division of Cardiovascular and Thoracic Surgery, Intermountain Heart Institute, Intermountain Medical Center, Murray, UT, United States.
authors.forename: John R
authors.initials: JR
authors.lastname: Doty
mesh_terms: D000925:Anticoagulants / Q000009:adverse effects / Q000627:therapeutic use*; D001021:Aortic Valve / Q000601:surgery; D001241:Aspirin / Q000009:adverse effects / Q000627:therapeutic use*; D006350:Heart Valve Prosthesis / Q000009:adverse effects; D019918:Heart Valve Prosthesis Implantation / Q000009:adverse effects*; D006470:Hemorrhage / Q000139:chemically induced; D006801:Humans; D013927:Thrombosis / Q000209:etiology* / Q000517:prevention & control*; D014859:Warfarin / Q000009:adverse effects / Q000627:therapeutic use*
chemical_list: D000925:Anticoagulants; D014859:Warfarin; D001241:Aspirin